[Outline of Guidelines 2004 for bone marker in osteoporosis].
Nishizawa
Yoshiki
Y
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
D000596:Amino Acids / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016723:Bone Remodeling; D001862:Bone Resorption / Q000175:diagnosis; D001842:Bone and Bones / Q000378:metabolism*; D024042:Collagen Type I / Q000032:analysis*; D050723:Fractures, Bone / Q000209:etiology; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy / Q000378:metabolism; D010455:Peptides / Q000032:analysis*; D017410:Practice Guidelines as Topic; D012306:Risk
D000596:Amino Acids; D015415:Biomarkers; D050071:Bone Density Conservation Agents; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; C036020:deoxypyridinoline